Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study to Evaluate the Feasibility and Safety of Hybrid Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Treatment of Patients With Colon Cancer

NCT04048421 is registered in ClinicalTrials.gov with Renmin Hospital of Wuhan University as lead sponsor.

NCT NCT04048421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04048421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study to Evaluate the Feasibility and Safety of Hybrid Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Treatment of Patients With Colon Cancer
Lead sponsor
Renmin Hospital of Wuhan University
Phase
Not applicable
Overall status
Unknown status
Start date
December 20, 2019
Completion date
November 30, 2025
Enrollment
55 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, natural orifice transluminal endoscopic surgery